Eli Lilly shares are trading higher after Deutsche Bank upgraded the stock from Hold to Buy and raised its price target from $725 to $1,025.
Portfolio Pulse from Benzinga Newsdesk
Eli Lilly shares are trading higher after Deutsche Bank upgraded the stock from Hold to Buy and raised its price target from $725 to $1,025.
August 12, 2024 | 12:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eli Lilly shares are trading higher following an upgrade from Deutsche Bank, which raised its rating from Hold to Buy and increased the price target from $725 to $1,025.
The upgrade from Deutsche Bank and the significant increase in the price target are strong positive signals for investors, likely leading to increased buying activity and a short-term rise in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100